Anita Dushyanth
Stock Analyst at Berenberg
(0.87)
# 2,898
Out of 4,496 analysts
5
Total ratings
60%
Success rate
-5.71%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $15.79 | +26.66% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $7.80 | +66.67% | 1 | Apr 27, 2022 | |
| RNLX Renalytix | Initiates: Buy | n/a | $0.30 | - | 1 | Jul 2, 2021 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | n/a | $1.17 | - | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | n/a | $19.37 | - | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $15.79
Upside: +26.66%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $7.80
Upside: +66.67%
Renalytix
Jul 2, 2021
Initiates: Buy
Price Target: n/a
Current: $0.30
Upside: -
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: n/a
Current: $1.17
Upside: -
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: n/a
Current: $19.37
Upside: -